Results 71 to 80 of about 490,842 (303)

Binding and entering: COVID finds a new home.

PLoS Pathogens, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility ...
Michelle N Vu, Vineet D Menachery
doaj   +1 more source

Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia [PDF]

Emerging Infectious Diseases, 2020
Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical ...
Katherine Laiton‐Donato, C. Julian Villabona-Arenas, José A. Usme-Ciro, Carlos Franco-Muñoz, Diego A. Álvarez-Díaz, Liz Stephany Villabona-Arenas, Susy Echeverría-Londoño, Zulma M. Cucunubá, Nicolás D. Franco‐Sierra, Astrid Carolina Flórez, Carolina Ferro, Nadim J. Ajami, Diana Marcela Walteros, Franklin Prieto, Carlos Andrés Durán, Martha L. Ospina-Martinez, Marcela Mercado   +16 more
openaire   +5 more sources

Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus [PDF]

, 2017
Background There are no longitudinal data on the changes in hematologic, hepatic, and renal function findings in patients with Middle East respiratory syndrome coronavirus (MERS‐CoV) infection. Methods This is a retrospective cohort study of 16 MERS‐
Abbasi, S., Al-Tawfiq, J. A., Babiker, M., Eltigani, M., Hinedi, K., Sunji, A.   +5 more
core   +1 more source

A Family Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections [PDF]

European Journal of Clinical Microbiology & Infectious Diseases, 2020
Abstract Background In December 2019, the outbreak of 2019 novel coronavirus disease (COVID-19) began in Wuhan, Hubei Province, China. The disease has rapidly spread from Wuhan to other provinces and other countries. Clinical and epidemiological knowledge is limited.
Xuesong Gao, Zheng Yuan, Di Yang, Hongjie Li, Yijin Zhang, Ping Gao, Xiaomin Liu, Wenshan Zhao, Te Xiao, Xuefei Duan   +9 more
openaire   +3 more sources

Methods for estimating the case fatality ratio for a novel, emerging infectious disease. [PDF]

, 2005
During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated. The authors propose a novel method for doing so based on the Kaplan-Meier survival procedure, jointly considering two ...
Anderson, RM, Chan, WS, Cox, DR, Donnelly, CA, Fraser, C, Ghani, AC, Griffin, JT, Hedley, AJ, Ho, LM, Lam, TH, Leung, GM   +10 more
core   +1 more source

Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms

Journal of Medical Case Reports, 2023
Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati, Mahdi Shahriari, Mohammad Reza Bordbar, Seyyed Bozorgmehr Hedayati, Mazyar Ziyaeyan, Marzieh Jamalidoust, Mehdi Kalani, Nahid Heydari Marandi   +7 more
doaj   +1 more source

SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

Emerging Infectious Diseases, 2021
We report persistent severe acute respiratory syndrome coronavirus 2 infection in a patient with HIV/AIDS; the virus developed spike N terminal domain and receptor binding domain neutralization resistance mutations.
Seth A. Hoffman, Cristina Costales, Malaya K. Sahoo, Srikanth Palanisamy, Fumiko Yamamoto, ChunHong Huang, Michelle Verghese, Daniel A. Solis, Mamdouh Sibai, Aruna Subramanian, Lucy S. Tompkins, Philip Grant, Robert W. Shafer, Benjamin A. Pinsky   +13 more
doaj   +1 more source

Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019

Current Opinion in Allergy & Clinical Immunology, 2021
Purpose of review In December 2019, a novel respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first described and named coronavirus disease 2019 (COVID-19). Although the knowledge base surrounding COVID-19 and SARS-CoV-2 has grown rapidly, significant gaps in our knowledge remain and
Timberlake, Dylan T., Strothman, Kasey, Grayson, Mitchell H.   +2 more
openaire   +2 more sources

A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom [PDF]

, 2020
Background: In December 2019 the coronavirus disease of 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, was identified in Wuhan, China.
Hunt, Madison, Koziatek, Christian
core  

Role of natural drugs in severe acute respiratory syndrome coronavirus 2: potential beneficial effects in prevention or prior treatment in elderly and cancer patients

Geriatric Care, 2020
In 2019, a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. It causes an acute respiratory disease, by involving the same receptor, i.e. the angiotensin-converting enzyme 2, as that
Eugenio Boccalone, Veronica Maria Lanni, Valerio Massimo Magro   +2 more
doaj   +1 more source